Edesa Biotech (NASDAQ:EDSA – Get Free Report) and Arcus Biosciences (NYSE:RCUS – Get Free Report) are both healthcare companies, but which is the superior business? Get Edesa Biotech alerts:Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Edesa Biotech N/A N/A -$7.19 million ($1.34) -3.93 Arcus Biosciences $117.00 million 31.20 -$353.00 million ($3.90) -7.35Risk & VolatilityEdesa Biotech has higher earnings, but lower revenue than Arcus Biosciences. ProfitabilityThis table compares Edesa Biotech and Arcus Biosciences’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Edesa Biotech N/A -286.52% -75.36% Arcus Biosciences -393.16% -89.54% -45.61%Insider and Institutional Ownership5.5% of Edesa Biotech shares are owned by institutional investors. Given Arcus Biosciences’ higher probable upside, analysts clearly believe Arcus Biosciences is more favorable than Edesa Biotech.